ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.68
-1.17%
US Tech 100
16,855.20
-0.76%
S&P 500
5,035.69
-1.57%
US Dollar vs CAD
1.37719
-0.04%
Bitcoin
57,319.19
-5.41%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Viatris Inc (VTRS)

  7. Viatris Inc (VTRS) News

VTRS Viatris Inc

11.57
0.00 (0.00%)
Pre Market
Last Updated: 03:29:44
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Viatris Inc VTRS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 11.57 03:29:44
Open Price Low Price High Price Close Price Previous Close
11.57
more quote information »

Recent News

Date Time Source Heading
4/16/202415:30PRNUSViatris to Report First Quarter 2024 Financial Results on..
4/15/202407:00PRNUSViatris Appoints Corinne Le Goff as Chief Commercial Officer
4/15/202405:59PRNCAViatris Announces Launch of First Bioequivalent Generic..
4/01/202405:59PRNUSViatris Announces the Launch of RYZUMVl™ (Phentolamine..
3/27/202405:59PRNUSViatris Hosts R&D Event Focusing on its Collaboration with..
3/05/202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202419:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202419:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
3/04/202417:11EDGAR2Form 144 - Report of proposed sale of securities
2/28/202406:39EDGAR2Form 8-K - Current report
2/28/202405:30PRNUSViatris Reports Fourth-Quarter and Full-Year 2023 Financial..
2/28/202400:00PRNUSViatris and Idorsia Enter Into Significant Global Research..
2/23/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202416:18EDGAR2Form 144 - Report of proposed sale of securities
2/05/202405:59PRNUSViatris to Announce Fourth Quarter and Full-Year 2023..
1/30/202415:40EDGAR2Form 8-K/A - Current report: [Amend]
1/19/202405:56PRNUSViatris recognised as a Top Employer 2024 in the UK for the..
1/05/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202419:28EDGAR2Form 144 - Report of proposed sale of securities
12/21/202315:05PRNUSViatris to Participate in 42nd Annual J.P. Morgan Healthcare..
12/15/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202316:04EDGAR2Form 8-K/A - Current report: [Amend]
12/15/202316:00EDGAR2Form 8-K - Current report
12/15/202315:45PRNUSViatris Continues its Preparations for Phase 2 of its..
12/15/202315:14EDGAR2Form 8-K - Current report
12/15/202315:12EDGAR2Form 8-K - Current report
12/15/202315:05PRNUSViatris Shareholders Re-elect All Nominated Directors and..
12/14/202316:31EDGAR2Form 144 - Report of proposed sale of securities
11/24/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/24/202315:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/24/202312:02EDGAR2Form 144 - Report of proposed sale of securities
11/14/202307:00PRNUSViatris to Participate in the Jefferies London Healthcare..
11/13/202307:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
11/07/202315:39EDGAR2Form 8-K - Current report
11/07/202315:02PRNUSViatris Reports Strong Financial and Operational Results for..
11/03/202315:36EDGAR2Form ARS - Annual Report to Security Holders
11/03/202315:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/03/202315:31EDGAR2Form DEF 14A - Other definitive proxy statements
10/30/202308:00PRNUSViatris to Host Webinar: The Power of Partnership to Address..
10/24/202315:32EDGAR2Form 8-K - Current report
10/24/202315:30EDGAR2Form PRE 14A - Other preliminary proxy statements
10/23/202308:00PRNUSViatris Named to Forbes' Annual List of the World's Best..
10/20/202316:18EDGAR2Form 8-K - Current report
10/20/202316:00PRNUSRajiv Malik to Retire as President of Viatris Effective..
10/18/202307:00PRNUSViatris Named to 3BL's 100 Best Corporate Citizens of 2023..
10/10/202308:29PRNUSViatris to Release Third Quarter 2023 Financial Results on..

Your Recent History

NASDAQ
VTRS
Viatris
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved